About Cytonus Therapeutics
Cytonus Therapeutics is a private company based in Carlsbad, California, incorporated in 2018 in Delaware. It has reported $14,388,095 raised in five offerings on Form D since December 2018. Its chief executive is Remo Moomiaie.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 2023 | Nov 6, 2023 | $11,703,095of $21.6M target | 19 | $615K | EquityRule 506(b) | Form D ↗ |
| Jan 29, 2022 | Feb 10, 2022 | $15,000of $1.0M target | 1 | $15,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Mar 5, 2021 | Mar 18, 2021 | $2,500,000of $5.0M target | 1 | $2.5M | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 21, 2020 | Apr 30, 2020 | $100,000of $1.0M target | 2 | $50,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 17, 2018 | Dec 26, 2018 | $70,000of $3.0M target | 2 | $35,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $14,388,095 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cytonus Therapeutics's Form D filed Nov 6, 2023.
RM
Remo Moomiaie
Chief Executive Officer and director
RK
Richard Klemke
Executive officer and director
JA
Jae An
Director
CT
Christopher Thorne
Director
Earlier filings also listed Manisha Narasimhan (director, last listed Feb 2022).